Drawing for BIOSQUARE

USPTO serial 79241595

BIOSQUARE

Reviewed by CopyMark Law Group

Reg. 5809316Status 739Registered
Filing date
Status date
Registration date
Jul 23, 2019
Examiner
SEVERSON, JUSTIN
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with BIOSQUARE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

minchul yang

minchul yang STIP LAW GROUP LLC40 W Chesapeake Ave, STE 506Towson, MD 21204United States

Goods and services

ClassDescriptionStatusFirst use
042Engineering research for medical, pharmaceutical, and biotechnology products; medical research; research for medical products; pharmaceutical research and development; medical research laboratory services for predicting disease; scientific research in the fields of biomedicine; bacteriological inspection of buildings, homes, water, and manufacturing facilities; blood analysis services; consultation and providing information in the fields of pharmacology; biochemical research; biotechnology research; chemical research; providing technical advice in the field of scientific research; providing technical advice in the field of technological research; providing information of scientific research in the fields of medicine, pharmacology, and biotechnology; design and development of computer software related to measuring machines and instruments; design and development of computer hardware related to measuring machines and instrumentsACTIVE—
044Medical services in the field of oncology; medical analysis services for cancer diagnosis and prognosis; RNA or DNA analysis for cancer diagnosis and prognosis; providing information in the field of cancer prevention, screening, diagnosis and treatment; medical analysis services for the diagnosis of cancer; medical testing for diagnostic or treatment purposes; medical testing services relating to the diagnosis and treatment of disease; medical analysis for the diagnosis and treatment of persons; laboratory analysis services relating to the treatment of persons; medical services relating to the removal, treatment and processing of human blood; provision of genetic testing for medical treatment purposes; provision of genetic information for medical treatment purposes; provision of gene therapy for medical treatment purposes; conducting of medical examinations; medical examination services; therapy services, namely, gene therapy, cell therapy, and chemical therapy; biopsy for medical treatment/diagnosis; blood testing for medical treatment/diagnosisACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 19, 2025NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Nov 19, 2025C75AREGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.—
Nov 17, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jul 23, 2025ES75TEAS SECTION 71 & 15 RECEIVED—
Jul 23, 2024REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Dec 1, 2019FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 13, 2019FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 13, 2019FIMPFINAL DISPOSITION PROCESSED—
Oct 23, 2019FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 3, 2019TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 23, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 7, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 7, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 3, 2019GPNXNOTIFICATION PROCESSED BY IB—
Apr 17, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 17, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 17, 2019OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Mar 26, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 26, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 25, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 25, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 9, 2018RFNPREFUSAL PROCESSED BY IB—
Oct 23, 2018RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Oct 23, 2018RFRRREFUSAL PROCESSED BY MPU—
Oct 11, 2018RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 10, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 6, 2018MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 2, 2018DOCKASSIGNED TO EXAMINER—
Oct 2, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 27, 2018REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance